Acetyltransferase machinery conserved in p300/CBP-family proteins

被引:38
|
作者
Yuan, LWC
Giordano, A [1 ]
机构
[1] Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
[2] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA
基金
美国国家卫生研究院;
关键词
p300; CBP; PCAT; histone/protein acetyltransferase; protein domains; protein structure;
D O I
10.1038/sj.onc.1205283
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CREB-binding protein (CBP) and p300 are highly, conserved and functionally related transcription coactivators and histone/protein acetyltransferases. They are, tumor suppressors, participate in a wide variety of physiological events, and serve as integrators among different signal transduction pathways. In this study, 11 distinct proteins that have a high degree of homology with the amino acid sequence of p300 have been identified in current protein databases. All of these, 11 proteins belong to either animal or plant multicellular organisms (higher eucaryotes). Conservation of p300/ CBP domains among these proteins was examined further by sequence alignment and pattern search. The domains of p300/CBP that are required for the HAT function, including PHD, putative CoA-binding, and ZZ domains, are conserved in all of these 11 proteins. This observation is consistent with the previous functional assays and indicates that they are a family of acetyltransferases, i.e. p300/CBP acetyltransferases (PCAT). TAZ domains (TAZ1 and/or TAZ2) of PCAT proteins may allow them to participate in transcription regulation by either directly recruiting transcription factors, acetylating them subsequently, or directing targeted acetylation of nucleosomal histones.
引用
收藏
页码:2253 / 2260
页数:8
相关论文
共 50 条
  • [1] Acetyltransferase machinery conserved in p300/CBP-family proteins
    L Wuchao Yuan
    Antonio Giordano
    Oncogene, 2002, 21 : 2253 - 2260
  • [2] Plant orthologs of p300/CBP:: conservation of a core domain in metazoan p300/CBP acetyltransferase-related proteins
    Bordoli, L
    Netsch, M
    Lüthi, U
    Lutz, W
    Eckner, R
    NUCLEIC ACIDS RESEARCH, 2001, 29 (03) : 589 - 597
  • [3] Chromatin recognition and regulation of the acetyltransferase CBP/p300
    Panne, D.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C1586 - C1586
  • [4] CBP/p300 acetyltransferase activity in hematologic malignancies
    Dutta, Ritika
    Tiu, Bruce
    Sakamoto, Kathleen M.
    MOLECULAR GENETICS AND METABOLISM, 2016, 119 (1-2) : 37 - 43
  • [5] Designing p300/CBP histone acetyltransferase inhibitors for cancer
    Cole, Philip A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [6] Functional analysis of the p300 acetyltransferase domain:: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity
    Bordoli, L
    Hüsser, S
    Lüthi, U
    Netsch, M
    Osmani, H
    Eckner, R
    NUCLEIC ACIDS RESEARCH, 2001, 29 (21) : 4462 - 4471
  • [7] Functional interaction between HBX and the histone acetyltransferase CBP/p300
    Cougot, D.
    Wu, Y.
    Caramel, J.
    Buendia, M.
    Neuveut, C.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S40 - S40
  • [8] Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP
    Zucconi, Beth E.
    Makofske, Jessica L.
    Meyers, David J.
    Hwang, Yousang
    Wu, Mingxuan
    Kuroda, Mitzi I.
    Cole, Philip A.
    BIOCHEMISTRY, 2019, 58 (16) : 2133 - 2143
  • [9] New Inhibitors of the Human p300/CBP Acetyltransferase Are Selectively Active against the Arabidopsis HAC Proteins
    Longo, Chiara
    Lepri, Andrea
    Paciolla, Andrea
    Messore, Antonella
    De Vita, Daniela
    di Patti, Maria Carmela Bonaccorsi
    Amadei, Matteo
    Madia, Valentina Noemi
    Ialongo, Davide
    Di Santo, Roberto
    Costi, Roberta
    Vittorioso, Paola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [10] Inhibition of histone acetyltransferase (HAT) activity by HBZ extends beyond the p300/CBP HAT family
    Diana G Wright
    Nicholas Polakowski
    Isabelle Lemasson
    Retrovirology, 11 (Suppl 1)